Display options
Cite
Grabs V, Nieman DC, Haller B, et al. The effects of oral hydrolytic enzymes and flavonoids on inflammatory markers and coagulation after marathon running: study protocol for a randomized, double-blind, placebo-controlled trial. BMC Sports Sci Med Rehabil. 2014;6(1):8doi: 10.1186/2052-1847-6-8.
Grabs, V., Nieman, D. C., Haller, B., Halle, M., & Scherr, J. (2014). The effects of oral hydrolytic enzymes and flavonoids on inflammatory markers and coagulation after marathon running: study protocol for a randomized, double-blind, placebo-controlled trial. BMC sports science, medicine & rehabilitation, 6(1), 8. https://doi.org/10.1186/2052-1847-6-8
Grabs, Viola, et al. "The effects of oral hydrolytic enzymes and flavonoids on inflammatory markers and coagulation after marathon running: study protocol for a randomized, double-blind, placebo-controlled trial." BMC sports science, medicine & rehabilitation vol. 6,1 (2014): 8. doi: https://doi.org/10.1186/2052-1847-6-8
Grabs V, Nieman DC, Haller B, Halle M, Scherr J. The effects of oral hydrolytic enzymes and flavonoids on inflammatory markers and coagulation after marathon running: study protocol for a randomized, double-blind, placebo-controlled trial. BMC Sports Sci Med Rehabil. 2014 Feb 22;6(1):8. doi: 10.1186/2052-1847-6-8. PMID: 24559067; PMCID: PMC3945524.
Copy Download .nbib Format: NLM
Share it on

BMC Sports Sci Med Rehabil. 2014 Feb 22;6(1):8. doi: 10.1186/2052-1847-6-8.

The effects of oral hydrolytic enzymes and flavonoids on inflammatory markers and coagulation after marathon running: study protocol for a randomized, double-blind, placebo-controlled trial.

BMC sports science, medicine & rehabilitation

Viola Grabs, David C Nieman, Bernhard Haller, Martin Halle, Johannes Scherr

Affiliations

  1. Department of Prevention, Rehabilitation and Sports Medicine, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich, Germany. [email protected].

PMID: 24559067 PMCID: PMC3945524 DOI: 10.1186/2052-1847-6-8

Abstract

BACKGROUND: Regular moderate intensity physical activity positively influences the immune system with a lower incidence of upper respiratory tract infections (URTI) and lower levels of pro-inflammatory markers. However, marathon running due to its strenuous and prolonged nature results in immune perturbations with a major increase in pro-inflammatory markers and subsequent increased incidence of URTI. Furthermore, marathon running results in muscle damage and changes in hemostasis that promote a pro-thrombotic state.Naturally occurring hydrolytic enzymes and flavonoids have antioxidant, anti-inflammatory and fibrinolytic effects, and may serve as countermeasures to exercise-induced inflammation, immune dysfunction and URTI.The aim of this study is to determine whether the ingestion of oral hydrolytic enzymes and flavonoids before and after a marathon attenuates post-race muscle damage and inflammation, counters pro-thrombotic changes in hemostasis and decreases URTI incidence.

METHODS/DESIGN: The Enzy-MagIC-study (Enzymes, Marathon runninG, Inflammation, Coagulation) is a randomized, double-blind, placebo-controlled, monocenter phase I trial. 160 healthy males (age 20-65 years) will be randomized to receive either placebo or treatment (Wobenzym, MUCOS Pharma, Berlin, Germany) which contains the hydrolytic enzymes (bromelain, trypsin) and the flavonoid rutoside. One week before the marathon race, participants will begin daily ingestion of the investigational product (3×4 tablets). Intake will be continued for two weeks after the race (3×2 tablets per day). Clinical and laboratory measures will be collected 5-weeks and 1-week before the race, and immediately-, 24-h, 72-h, and 2 weeks after the race. The primary endpoint is the influence of the treatment on the pre-to-post marathon race plasma concentration change of the inflammatory marker interleukin-6 (IL-6). Secondary endpoints include the effect of treatment on salivary IgA concentration and the frequency of upper respiratory tract infections (URTI) for two weeks post-marathon as determined by the Wisconsin Upper Respiratory Symptom Survey (WURSS-24). Furthermore, changes of muscular and rheological parameters will be measured before and after the marathon race.

DISCUSSION: We hypothesize that marathon-induced inflammatory perturbations and the incidence of subsequent URTI, muscular damage, and changes of hemostasis can be positively influenced by the anti-edematous, anti-inflammatory, antioxidant, and fibrinolytic effects of oral hydrolytic enzymes and flavonoids (Wobenzym).

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01916408.

References

  1. Crit Rev Oncog. 1997;8(1):47-69 - PubMed
  2. Med Sci Sports Exerc. 2012 Jan;44(1):18-26 - PubMed
  3. J Immunol. 2010 Jun 15;184(12):6815-21 - PubMed
  4. Mol Nutr Food Res. 2005 Mar;49(3):239-46 - PubMed
  5. Clin Exp Rheumatol. 2006 Jan-Feb;24(1):25-30 - PubMed
  6. J Physiol. 1999 Feb 15;515 ( Pt 1):287-91 - PubMed
  7. Pain. 1987 Aug;30(2):191-197 - PubMed
  8. Nephrol Dial Transplant. 1996 Jun;11(6):987-9 - PubMed
  9. Burns. 2001 Nov;27(7):709-16 - PubMed
  10. Cell Mol Life Sci. 2001 Aug;58(9):1234-45 - PubMed
  11. Am J Clin Pathol. 2002 Dec;118(6):856-63 - PubMed
  12. JAMA. 2001 Jul 18;286(3):327-34 - PubMed
  13. Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):2047-52 - PubMed
  14. Free Radic Biol Med. 2006 Dec 15;41(12):1727-46 - PubMed
  15. Biochem J. 1990 Feb 1;265(3):621-36 - PubMed
  16. Scand J Med Sci Sports. 2006 Aug;16(4):287-93 - PubMed
  17. Clin Immunol. 2008 Mar;126(3):345-52 - PubMed
  18. Mol Nutr Food Res. 2007 Jun;51(6):684-91 - PubMed
  19. Am J Med. 2006 Nov;119(11):937-42 - PubMed
  20. Med Sci Sports Exerc. 2009 Jul;41(7):1467-75 - PubMed
  21. In Vivo. 1999 Jan-Feb;13(1):7-12 - PubMed
  22. In Vivo. 2005 Mar-Apr;19(2):417-21 - PubMed
  23. Am J Clin Nutr. 2002 Jul;76(1):93-9 - PubMed
  24. Clin Rheumatol. 2004 Oct;23(5):410-5 - PubMed
  25. Circulation. 2000 Apr 18;101(15):1767-72 - PubMed
  26. Eur J Appl Physiol. 2000 Dec;83(6):512-5 - PubMed
  27. Health Qual Life Outcomes. 2009 Aug 12;7:76 - PubMed
  28. Circ Res. 2002 Mar 8;90(4):465-72 - PubMed
  29. J Appl Physiol (1985). 2001 Jul;91(1):109-14 - PubMed
  30. Physiol Rev. 2008 Oct;88(4):1379-406 - PubMed
  31. J Athl Train. 1997 Oct;32(4):344-9 - PubMed
  32. Med Sci Sports Exerc. 2011 Oct;43(10):1819-27 - PubMed
  33. J Immunol. 2005 Sep 15;175(6):3463-8 - PubMed
  34. Clin Immunol. 2008 Jul;128(1):66-74 - PubMed
  35. Biochem Pharmacol. 1986 Jan 15;35(2):237-45 - PubMed
  36. FEBS Lett. 1997 Jun 2;409(1):12-6 - PubMed
  37. Med Sci Sports Exerc. 2007 Sep;39(9):1561-9 - PubMed
  38. Nutr Rev. 2008 Jun;66(6):310-20 - PubMed
  39. Arzneimittelforschung. 2000 Aug;50(8):728-38 - PubMed
  40. J Appl Physiol (1985). 2005 Apr;98(4):1154-62 - PubMed
  41. J Allergy Clin Immunol. 2004 Nov;114(5):997-1008; quiz 1009 - PubMed
  42. J Surg Res. 2006 Jun 15;133(2):150-8 - PubMed
  43. Br J Sports Med. 2003;37(5):433-5 - PubMed
  44. Thromb Haemost. 1996 Nov;76(5):738-42 - PubMed
  45. Adv Immunol. 1993;54:1-78 - PubMed
  46. Circulation. 2002 Mar 5;105(9):1135-43 - PubMed
  47. Mediators Inflamm. 2008;2008:109502 - PubMed

Publication Types